Professor Wei Chen NAI Senior Member Induction
June 12, 2024
Lu Alleruzzo, CEO, Tomas Hode, PhD, CIO, and President, along with the Immunophotonics Team, extend their congratulations to Professor Wei…
Dr. Robert CG Martin II, M.D, PhD Presenting his IRE Data at the Central Surgical Association 81st Annual Meeting
June 5, 2024
Immunophotonics is excited to share that Dr. Robert CG Martin II, M.D, PhD, PACS, who serves as Principal Investigator and…
ASCO Chicago, May 31 – June 3, 2024
June 5, 2024
Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) will be in Chicago at the ASCO (American…
Immunophotonics Announces the Addition of Jacqueline Hess to its Advisory Board
May 1, 2024
Immunophotonics, Inc. is delighted to introduce Jacqueline Hess as the newest addition to our advisory board. Ms. Hess has over 25 years…
European Conference on Interventional Oncology (ECIO), April 28 – May 1, 2024
April 24, 2024
Tomas Hode, PhD, who serves as the Co-Founder, CIO, and President at Immunophotonics, Inc., will be attending the European Conference…
Swiss Biotech Day, April 22 – 23, 2024
April 24, 2024
Immunophotonics is thrilled to share that Dr. Theresa Visarius from Immunophotonics Switzerland (IPS Biopharma) will be attending the Swiss Biotech…
AngioDynamics International Life Symposium “The Human Touch, Behind Innovation” March 21–23, 2024
March 20, 2024
Tomas Hode, PhD, who serves as the Co-Founder, CIO, and President at Immunophotonics, Inc. is eager to attend the AngioDynamics…
MOBIO to feature Immunophotonics as the Member Highlight for March
March 13, 2024
Immunophotonics to be showcased as the Member Highlight for March by The Missouri Biotechnology Association (MOBIO), both on their homepage…
AngioDynamics and Immunophotonics Announces Partnership to Explore the Power of Immunotherapy
February 28, 2024
Immunophotonics Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President have announced a partnership that will combine use of…
Immunophotonics presenting at the Global Life Science Partnering & Investor Conference February 27-29, 2024
February 28, 2024
Immunophotonics, Inc. is grateful to NCI (National Cancer Institute) SBIR Investor Initiatives Team for providing us the opportunity to showcase…